Asuragen, Inc. Names Colin Hill Senior Vice President Of Commercial Operations

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a global molecular diagnostics company, announced today that it has appointed Colin Hill as Senior Vice President of Commercial Operations. Colin will lead the product commercialization strategy including business development, sales, marketing, scientific affairs and technical services.

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i